Search research articles
Contact Us
Filters
Showing results (1-10 of 73) with videos related to
Page
of 8
Sort By:
Health Physics
|
October 12, 2005
Radiation protectants: current status and future prospects
Thomas M Seed
Expert Opinion on Drug Safety
|
September 19, 2019
The efficacy and safety of amifostine for the acute radiation syndrome
Vijay K Singh, Thomas M Seed
Expert Opinion on Investigational Drugs
|
January 19, 2023
Development of gamma-tocotrienol as a radiation medical countermeasure for the acute radiation syndrome: current status and future perspectives
Vijay K Singh, Thomas M Seed
Drug Discovery Today
|
December 14, 2023
The potential value of 5-androstenediol in countering acute radiation syndrome
Vijay K Singh, Thomas M Seed
Drug Discovery Today
|
October 16, 2020
Entolimod as a radiation countermeasure for acute radiation syndrome
Vijay K Singh, Thomas M Seed
International Journal of Radiation Biology
|
June 27, 2017
A review of radiation countermeasures focusing on injury-specific medicinals and regulatory approval status: part I. Radiation sub-syndromes, animal models and FDA-approved countermeasures
Vijay K Singh, Thomas M Seed
International Journal of Radiation Biology
|
August 17, 2021
Radiation countermeasures for hematopoietic acute radiation syndrome: growth factors, cytokines and beyond
Vijay K Singh, Thomas M Seed
Expert Opinion on Drug Discovery
|
July 8, 2025
New opportunities and current challenges using animal models for the discovery of novel countermeasures for acute radiation syndrome
Vijay K Singh, Thomas M Seed
Expert Opinion on Investigational Drugs
|
May 26, 2020
BIO 300: a promising radiation countermeasure under advanced development for acute radiation syndrome and the delayed effects of acute radiation exposure
Vijay K Singh, Thomas M Seed
Expert Opinion on Drug Discovery
|
July 15, 2022
Acute radiation syndrome drug discovery using organ-on-chip platforms
Vijay K Singh, Thomas M Seed
Page
of 8
Search research articles
Search
Showing results (1-10 of 73) with videos related to
Sort By:
Page
of 8
Health Physics
|
October 12, 2005
Radiation protectants: current status and future prospects
Thomas M Seed
Expert Opinion on Drug Safety
|
September 19, 2019
The efficacy and safety of amifostine for the acute radiation syndrome
Vijay K Singh, Thomas M Seed
Expert Opinion on Investigational Drugs
|
January 19, 2023
Development of gamma-tocotrienol as a radiation medical countermeasure for the acute radiation syndrome: current status and future perspectives
Vijay K Singh, Thomas M Seed
Drug Discovery Today
|
December 14, 2023
The potential value of 5-androstenediol in countering acute radiation syndrome
Vijay K Singh, Thomas M Seed
Drug Discovery Today
|
October 16, 2020
Entolimod as a radiation countermeasure for acute radiation syndrome
Vijay K Singh, Thomas M Seed
International Journal of Radiation Biology
|
June 27, 2017
A review of radiation countermeasures focusing on injury-specific medicinals and regulatory approval status: part I. Radiation sub-syndromes, animal models and FDA-approved countermeasures
Vijay K Singh, Thomas M Seed
International Journal of Radiation Biology
|
August 17, 2021
Radiation countermeasures for hematopoietic acute radiation syndrome: growth factors, cytokines and beyond
Vijay K Singh, Thomas M Seed
Expert Opinion on Drug Discovery
|
July 8, 2025
New opportunities and current challenges using animal models for the discovery of novel countermeasures for acute radiation syndrome
Vijay K Singh, Thomas M Seed
Expert Opinion on Investigational Drugs
|
May 26, 2020
BIO 300: a promising radiation countermeasure under advanced development for acute radiation syndrome and the delayed effects of acute radiation exposure
Vijay K Singh, Thomas M Seed
Expert Opinion on Drug Discovery
|
July 15, 2022
Acute radiation syndrome drug discovery using organ-on-chip platforms
Vijay K Singh, Thomas M Seed
Page
of 8